BR0200879A - Combinação de antibiotico polìmeros-antibióticos - Google Patents

Combinação de antibiotico polìmeros-antibióticos

Info

Publication number
BR0200879A
BR0200879A BR0200879-3A BR0200879A BR0200879A BR 0200879 A BR0200879 A BR 0200879A BR 0200879 A BR0200879 A BR 0200879A BR 0200879 A BR0200879 A BR 0200879A
Authority
BR
Brazil
Prior art keywords
antibiotic
polymers
combination
acid esters
antibiotics
Prior art date
Application number
BR0200879-3A
Other languages
English (en)
Inventor
Sebastian Vogt
Matthias Schnabelrauch
Klaus-Dieter Kuehn
Original Assignee
Heraeus Kulzer Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer Gmbh & Co Kg filed Critical Heraeus Kulzer Gmbh & Co Kg
Publication of BR0200879A publication Critical patent/BR0200879A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Socks And Pantyhose (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMBINAçãO DE ANTIBIóTICO/POLìMEROS-ANTIBIóTICOS". A presente invenção refere-se a uma combinação de antibiótico/polímeros antibióticos que sob condições fisiológicas possibilitam uma liberação contínua de antibióticos por um período de tempo de vários dias e que pode ser empregado na medicina humana e veterinária. A combinação de antibiótico/polímeros antibióticos da presente invenção é caracterizada pelo fato de que em uma mistura polímera homogênea consistindo em um ou mais polímeros hidrófobos do grupo dos poli(ésteres do ácido metacrílico), dos poli(ésteres do ácido acrílico), dos poli(ésteres do ácido co-acrílico-ésteres do ácido metacrílico) e um ou mais polímeros hidrofílicos do grupo dos poliéteres, nos quais são suspensos um ou mais antibióticos ligeiramente hidrossolúveis dos grupos dos antibióticos-aminoglicosídeo, dos antibióticos-lincosamida, dos antibióticos-tetraciclina, dos antibióticos-quinolona e eventualmente um antibiótico facilmente solúvel em água dos grupos dos antibióticos-aminoglicosídeos, dos antibióticos-lincosamida e dos antibióticos-tetraciclina, e eventualmente um ou mais agentes auxiliares orgânicos e esta suspensão forma um composto.
BR0200879-3A 2001-03-22 2002-03-21 Combinação de antibiotico polìmeros-antibióticos BR0200879A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10114247A DE10114247A1 (de) 2001-03-22 2001-03-22 Antibiotikum-/Antibiotika-Polymer-Kombination

Publications (1)

Publication Number Publication Date
BR0200879A true BR0200879A (pt) 2003-03-11

Family

ID=7678694

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0200879-3A BR0200879A (pt) 2001-03-22 2002-03-21 Combinação de antibiotico polìmeros-antibióticos

Country Status (32)

Country Link
US (2) US20020150549A1 (pt)
EP (1) EP1243259B1 (pt)
JP (1) JP3579676B2 (pt)
CN (1) CN1192057C (pt)
AT (1) ATE271857T1 (pt)
AU (1) AU772291B2 (pt)
BG (1) BG65475B1 (pt)
BR (1) BR0200879A (pt)
CA (1) CA2378487C (pt)
CZ (1) CZ2002867A3 (pt)
DE (2) DE10114247A1 (pt)
DK (1) DK1243259T3 (pt)
EE (1) EE200200154A (pt)
ES (1) ES2225670T3 (pt)
GE (1) GEP20053448B (pt)
HR (1) HRP20020241B1 (pt)
HU (1) HUP0201042A2 (pt)
IL (1) IL148704A (pt)
IS (1) IS2500B (pt)
MD (1) MD2380C2 (pt)
MX (1) MXPA02003005A (pt)
NO (1) NO20021388L (pt)
NZ (1) NZ517921A (pt)
PL (1) PL352921A1 (pt)
PT (1) PT1243259E (pt)
RU (1) RU2229896C2 (pt)
SA (1) SA02230034B1 (pt)
SK (1) SK286300B6 (pt)
TR (1) TR200402037T4 (pt)
UA (1) UA72271C2 (pt)
YU (1) YU18102A (pt)
ZA (1) ZA200202253B (pt)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020163504A1 (en) * 2001-03-13 2002-11-07 Pallakoff Matthew G. Hand-held device that supports fast text typing
DE10261241A1 (de) * 2002-12-20 2004-07-15 3M Espe Ag Dentalmaterial mit bakteriostatischen und/oder bakteriziden Substanzen
WO2004062588A2 (en) * 2003-01-06 2004-07-29 University Of Utah Water-soluble polymeric bone-targeting drug delivery system
PL1603603T3 (pl) * 2003-02-28 2015-07-31 Biointeractions Ltd System sieci polimerowych dla urządzeń medycznych oraz sposoby zastosowania
US7279174B2 (en) * 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
ATE447981T1 (de) * 2003-07-17 2009-11-15 Bioretec Oy Synthetische, bioabsorbierbare polymer- materialien und implantate
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
RU2296587C2 (ru) * 2005-04-28 2007-04-10 Закрытое акционерное общество "МедСил" Способ изготовления изделий из полиуретана с антисептическим покрытием, изделие, полученное этим способом, и способ нанесения антисептического покрытия на изделие из полиуретана
US20070082029A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
EP1787627A1 (en) * 2005-11-17 2007-05-23 3M Innovative Properties Company Anti-microbial dental impression material
RU2335510C2 (ru) * 2006-02-22 2008-10-10 Институт высокомолекулярных соединений РАН Водорастворимые полимерные комплексы антибиотиков-аминогликозидов
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US8167847B2 (en) 2006-06-22 2012-05-01 Excelsior Medical Corporation Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly
US9700710B2 (en) 2006-06-22 2017-07-11 Excelsior Medical Corporation Antiseptic cap equipped syringe
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
NZ578341A (en) * 2007-01-21 2011-06-30 Hemoteq Ag Method for producing a coated catheter balloon
CA2679413C (en) * 2007-03-07 2014-05-06 Med-El Elektromedizinische Geraete Gmbh Implantable device with removable magnet
WO2008112592A1 (en) * 2007-03-09 2008-09-18 Anthem Orthopaedics Llc Implantable medicament delivery device and delivery tool and method for use therewith
US8124601B2 (en) * 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
EP2395982B1 (en) * 2008-12-23 2014-10-22 Surmodics Pharmaceuticals, Inc. An implantable composite comprising a tacky biocompatible polymer film and a releasable bioactive agent
AU2010218035B2 (en) * 2009-02-25 2014-05-15 Orthobond Corp. Anti- infective functionalized surfaces and methods of making same
US8927004B1 (en) 2014-06-11 2015-01-06 Silver Bullet Therapeutics, Inc. Bioabsorbable substrates and systems that controllably release antimicrobial metal ions
US8221396B2 (en) 2009-08-27 2012-07-17 Silver Bullet Therapeutics, Inc. Bone implants for the treatment of infection
US9821094B2 (en) 2014-06-11 2017-11-21 Silver Bullet Therapeutics, Inc. Coatings for the controllable release of antimicrobial metal ions
US9114197B1 (en) 2014-06-11 2015-08-25 Silver Bullett Therapeutics, Inc. Coatings for the controllable release of antimicrobial metal ions
US10265435B2 (en) 2009-08-27 2019-04-23 Silver Bullet Therapeutics, Inc. Bone implant and systems and coatings for the controllable release of antimicrobial metal ions
EP3037066B1 (en) 2010-11-12 2017-08-16 Silver Bullet Therapeutics Inc. Bone implant that controllably releases silver
DE102011014386A1 (de) 2011-03-11 2012-09-13 Hemoteq Ag Endoprothese mit einer Wirkstoffbeschichtung
WO2012162259A2 (en) 2011-05-20 2012-11-29 Excelsior Medical Corporation Caps for cannula access devices
US9867975B2 (en) * 2011-05-23 2018-01-16 Excelsior Medical Corporation Antiseptic line cap
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
ES2797649T3 (es) 2011-07-12 2020-12-03 Icu Medical Inc Dispositivo para entrega de agente antimicrobiano en un catéter transdérmico
US8834772B2 (en) 2011-12-07 2014-09-16 Biomet Manufacturing, Llc Antimicrobial methacrylate cements
CN103212087A (zh) * 2013-04-19 2013-07-24 西北农林科技大学 抗生素-壳聚糖共价复合物及其制备方法和在制备抗肿瘤药物中的应用
AU2015252808B2 (en) 2014-05-02 2019-02-21 Excelsior Medical Corporation Strip package for antiseptic cap
US9452242B2 (en) 2014-06-11 2016-09-27 Silver Bullet Therapeutics, Inc. Enhancement of antimicrobial silver, silver coatings, or silver platings
CN104629279B (zh) * 2015-02-03 2016-04-06 安徽民祯生物工程有限公司 一种细菌素抑菌保鲜生物复合膜
MD4399C1 (ro) * 2015-02-19 2016-09-30 Государственный Университет Молд0 Material polimeric cu proprietăţi antibacteriene
WO2016182822A1 (en) 2015-05-08 2016-11-17 Icu Medical, Inc. Medical connectors configured to receive emitters of therapeutic agents
HUE058354T2 (hu) 2016-07-14 2022-07-28 Hollister Inc Hidrofil bevonattal rendelkezõ higiénikus orvosi eszközök és eljárások azok kialakítására
EP4194043A1 (en) 2016-10-14 2023-06-14 ICU Medical, Inc. Sanitizing caps for medical connectors
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
JP7560865B2 (ja) * 2018-01-31 2024-10-03 ケラメッド インコーポレーテッド 眼内インプラント用の抗微生物性ポリマ
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
AU2019384564B2 (en) 2018-11-21 2023-11-23 Icu Medical, Inc. Antimicrobial device comprising a cap with ring and insert
JP2024500319A (ja) 2020-12-07 2024-01-09 アイシーユー・メディカル・インコーポレーテッド 腹膜透析キャップ、システム、及び方法
CN114732019A (zh) * 2022-05-09 2022-07-12 中国科学院城市环境研究所 一种组合物及应用和抑制或消杀金黄色葡萄球菌的方法
EP4703048A1 (de) 2024-09-03 2026-03-04 Heraeus Medical GmbH Vorrichtung zur beschichtung von implantaten und zugehöriges verfahren

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3566874A (en) * 1968-08-13 1971-03-02 Nat Patent Dev Corp Catheter
US3857932A (en) * 1970-09-09 1974-12-31 F Gould Dry hydrophilic acrylate or methacrylate polymer prolonged release drug implants
DE2320373B2 (de) * 1973-04-21 1978-04-06 Merck Patent Gmbh, 6100 Darmstadt Antibioticahaltiges Mittel und seine Verwendung als chirurgisches Kunststoffmaterial
DE2511122B2 (de) * 1975-03-14 1977-06-08 Vorprodukt fuer die zubereitung von knochenzement
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
US4479795A (en) * 1979-06-29 1984-10-30 The Procter & Gamble Company Antimicrobial polymer compositions
DE3204551A1 (de) * 1982-02-10 1983-08-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films
US4603152A (en) * 1982-11-05 1986-07-29 Baxter Travenol Laboratories, Inc. Antimicrobial compositions
US4917686A (en) * 1985-12-16 1990-04-17 Colorado Biomedical, Inc. Antimicrobial device and method
IL78826A (en) * 1986-05-19 1991-05-12 Yissum Res Dev Co Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
US5019378A (en) * 1987-12-29 1991-05-28 Cuno, Incorporated Elastomeric composition containing therapeutic agents and articles manufactured therefrom
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5330746A (en) * 1988-05-03 1994-07-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dental varnish composition, and method of use
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5438076A (en) * 1988-05-03 1995-08-01 Perio Products, Ltd. Liquid polymer composition, and method of use
US5165952A (en) * 1989-01-18 1992-11-24 Becton, Dickinson And Company Anti-infective and antithrombogenic medical articles and method for their preparation
US5525348A (en) * 1989-11-02 1996-06-11 Sts Biopolymers, Inc. Coating compositions comprising pharmaceutical agents
US5261896A (en) * 1990-01-10 1993-11-16 Rochester Medical Corporation Sustained release bactericidal cannula
RU1776100C (ru) * 1990-05-03 1995-01-09 Санкт-Петербургский государственный университет технологии и дизайна (институт текстильной и легкой промышленности им.С.М.Кирова) Способ получения биологически активных хирургических нитей
ATE112163T1 (de) * 1991-01-03 1994-10-15 Glaxo Canada Verfahren zur herstellung einer festem pharmazeutischen zusammensetzung.
US5217493A (en) * 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
US5554147A (en) * 1994-02-01 1996-09-10 Caphco, Inc. Compositions and devices for controlled release of active ingredients
JP3087105B2 (ja) * 1995-04-20 2000-09-11 敏 瀧川 シリコンオイルとポリメタアクリル酸アルキルエステルよりなる塗剤
EP0844891A4 (en) * 1995-08-11 2004-05-06 Dow Chemical Co HYPER COMBED POLYMER CONJUGATES
US5681289A (en) * 1995-08-14 1997-10-28 Medicinelodge Inc. Chemical dispensing system
US6110483A (en) * 1997-06-23 2000-08-29 Sts Biopolymers, Inc. Adherent, flexible hydrogel and medicated coatings
RU2157244C2 (ru) * 1998-11-02 2000-10-10 Институт нефтехимии и катализа АН РБ и УНЦ РАН Способ получения материала с антимикробными свойствами

Also Published As

Publication number Publication date
SA02230034B1 (ar) 2006-12-05
SK286300B6 (en) 2008-07-07
ATE271857T1 (de) 2004-08-15
CN1192057C (zh) 2005-03-09
DE10114247A1 (de) 2002-10-10
CA2378487A1 (en) 2002-09-22
HUP0201042A2 (hu) 2003-02-28
EE200200154A (et) 2002-12-16
IL148704A0 (en) 2002-09-12
NO20021388D0 (no) 2002-03-20
CN1376735A (zh) 2002-10-30
HRP20020241A2 (en) 2002-12-31
RU2229896C2 (ru) 2004-06-10
MD2380B2 (en) 2004-02-29
DK1243259T3 (da) 2004-11-01
MD2380C2 (ro) 2004-08-31
IL148704A (en) 2007-09-20
BG106455A (en) 2002-10-31
SK3902002A3 (en) 2002-10-08
MXPA02003005A (es) 2003-08-20
TR200402037T4 (tr) 2004-10-21
YU18102A (sh) 2004-11-25
MD20020072A (en) 2002-11-30
CA2378487C (en) 2008-08-26
US20080058733A1 (en) 2008-03-06
HRP20020241B1 (en) 2005-06-30
NZ517921A (en) 2003-08-29
BG65475B1 (bg) 2008-09-30
HU0201042D0 (pt) 2002-05-29
GEP20053448B (en) 2005-02-25
JP2002315823A (ja) 2002-10-29
ES2225670T3 (es) 2005-03-16
IS2500B (is) 2009-03-15
EP1243259B1 (de) 2004-07-28
PL352921A1 (en) 2002-09-23
CZ2002867A3 (cs) 2002-11-13
DE50200680D1 (de) 2004-09-02
UA72271C2 (en) 2005-02-15
US20020150549A1 (en) 2002-10-17
EP1243259A1 (de) 2002-09-25
IS6272A (is) 2002-09-22
PT1243259E (pt) 2004-11-30
JP3579676B2 (ja) 2004-10-20
ZA200202253B (en) 2002-10-10
NO20021388L (no) 2002-09-23
AU772291B2 (en) 2004-04-22
AU2755802A (en) 2002-09-26

Similar Documents

Publication Publication Date Title
BG106455A (en) Antibiotic, antibiotic polymer composition
Bohl et al. Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation
PT1327446E (pt) Composicoes de oxicodona de libertacao controlada
ES2951187T3 (es) Polimerosomas de fumarato
PT885014E (pt) Composicoes farmaceuticas contendo polimeros orto ester tamponados
EP3691649A1 (en) Compositions and methods for wound treatment
Chidchai et al. Development of photo-crosslinked chitosan-methacrylate hydrogel incorporated with ciprofloxacin as dressing for infected wounds
SA02230037B1 (ar) مستحضر مضاد حيوي antibiotic / مضادات حيوية antibiotics يتميز بإنتشار متأخر للمكون الفعال
KR910009241A (ko) 치근막 질환 치료용 서방성 조성물
Xue et al. Inhibiting synovial inflammation and promoting cartilage repair in rheumatoid arthritis using a matrix metalloproteinase-binding hydrogel
Han et al. Microenvironment‐Responsive Hydrogel Reduces Seizures After Traumatic Brain Injury in Juvenile Rats by Reducing Oxidative Stress and Hippocampal Inflammation
Sivalingam et al. Zinc protects against indomethacin-induced damage in the rat small intestine
Lee et al. Nanoparticle-encapsulated P2X7 receptor antagonist in a pH-sensitive polymer as a potential local drug delivery system to acidic inflammatory environments
Azadi Boroujeni et al. Designing a novel chitosan-based periofilm containing metronidazole–ciprofloxacin
PT1729732E (pt) Matrizes de hidrogeles aniónicos de libertação modificada dependente do ph como veículos de fármacos
Harshad Taste masking by functional cross linked copolymers and sustain release of drug through interpenetrating polymer network with sodium alginate and Κ-Carreganeen biopolymers
RU2812223C2 (ru) Применение тотарола и фармацевтическая композиция, содержащая тотарол
WO2026039529A1 (en) Programmable photocurable poly(beta-amino ester) particles for drug delivery
CN121221519A (zh) 一种以纤维微藻为主体的递送系统及其制备方法与应用
CN1244129A (zh) 二甲硅油作为转运和载体系统和/或药物释放系统的用途
Nair et al. Formulation and in Vitro-in Vivo evaluation of sustained release chitosan microspheres containing mefanamic acid
COCHRANE et al. University ofMinnesota Medical Bulletin

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/726; A61P 31/00

Ipc: A61K 31/726 (2011.01), A61P 31/00 (2011.01)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2156 DE 02/05/2012.